Thomas Jefferson University
Thomas Jefferson University (Jefferson) traces its roots to 1824 in Philadelphia, Pennsylvania. Jefferson is a private health related research, physician training, graduate school and patient care institution. The university is affiliated with the Jefferson Medical College, Jefferson College of Graduate Studies and the Jefferson College of Health Professions and several local hospitals. Jefferson is consistently rated in the top tier of health care educational and research institutions in the USA. Jefferson publishes research abstracts, newsletters and stories on the status of on-going research.
Philadelphia, PA 19107-5587
Curry spice component may help slow prostate tumor growth
Curcumin, an active component of the Indian curry spice turmeric, may help slow down tumor growth in castration-resistant prostate cancer patients on androgen deprivation therapy (ADT), a study from researchers ...
10 hours ago |
4.5 / 5 (6) |
0
|
Researchers show benefits of local anesthesia after knee replacement surgery
Researchers at the Rothman Institute at Jefferson have shown that local anesthesia delivered through a catheter in the joint, intraarticularly, may be more beneficial than traditional opioids such as morphine and Oxycontin ...
15 hours ago |
not rated yet |
0
Rothman at Jefferson research suggests abandon convention in diagnosing periprosthetic joint infection
In their search for new, better ways to diagnose periprosthetic joint infection, Rothman Institute at Jefferson researchers have discovered that measurement of C-reactive protein in the synovial fluid is extremely accurate, ...
Feb 08, 2012 |
not rated yet |
0
Researchers find epidural steroid injections do not benefit spine patients
Researchers at the Rothman Institute at Jefferson examined data on patients being treated for lumbar stenosis and the degenerative spine condition spondylolisthesis and found that patients who received epidural steroid injections ...
Feb 07, 2012 |
not rated yet |
0
Research suggests use of LE strips to diagnose PJI
Rothman Institute at Jefferson joint researchers continue to seek better ways to diagnose and subsequently treat periprosthetic joint infection (PJI) in patients following total joint arthroplasty. Their latest research shows ...
Feb 07, 2012 |
not rated yet |
0
Drugs targeting chromosomal instability may fight a particular breast cancer subtype
Another layer in breast cancer genetics has been peeled back. A team of researchers at Jefferson's Kimmel Cancer Center (KCC) led by Richard G. Pestell, M.D., PhD., FACP, Director of the KCC and Chair of the Department of ...
Feb 06, 2012 |
5 / 5 (1) |
0
|
Brachytherapy reduced death rates in high-risk prostate cancer patients, study finds
Brachytherapy for high-risk prostate cancers patients has historically been considered a less effective modality, but a new study from radiation oncologists at the Kimmel Cancer Center at Jefferson suggests otherwise. A population-based ...
Jan 25, 2012 |
4 / 5 (1) |
0
Allergy to Plavix can be overcome: study
Allergies to Plavix, also know by its chemical name, Clopidogrel occur in about six percent of patients given the drug, vital for the prevention of life-threatening stent thrombosis after angioplasty and percutaneous coronary ...
Medicine & Health / Medications
Jan 16, 2012 |
not rated yet |
0
Cabazitaxel with radiation and hormone therapy may improve prostate cancer survival
Jefferson's Kimmel Cancer Center has started a Phase I clinical trial investigating the latest prostate cancer chemotherapy drug to extend survival, Cabazitaxel, in combination with radiation and hormone therapy. This first-of-its-kind ...
Jan 12, 2012 |
not rated yet |
0
Obesity and cancer screening: Do race and gender also play a role?
Researchers in Family and Community Medicine at Thomas Jefferson University recently found that obesity was linked to higher rates of prostate cancer screening across all races/ethnic differences and lower rates of cervical ...
Jan 09, 2012 |
not rated yet |
0
|
Researchers identify potential target to delay metastatic pancreatic cancer and prolong survival
Often, and without much warning, pancreatic cancer cells slip through the endothelial cells, head into the blood and out to other parts of the body to metastasize, making it one of the deadliest and hardest to treat cancers ...
Dec 21, 2011 |
not rated yet |
0
When standard treatment fails: Jefferson to start unique immunotherapy for brain tumor patients
Physicians at the Jefferson Hospital for Neuroscience (JHN), the region's only dedicated hospital, are tackling a particularly aggressive brain cancer that even surgery, chemotherapy and radiation often fail to treat with ...
Dec 14, 2011 |
5 / 5 (2) |
0
Researchers mirror human response to bacterial infection and resolution in mice
Imitating human diseases using an animal model is a difficult task, but Thomas Jefferson University researchers have managed to come very close.
Dec 14, 2011 |
not rated yet |
0
|
SABCS: Loss of RB in triple negative breast cancer associated with favorable clinical outcome
Researchers at the Thomas Jefferson University Hospital and Kimmel Cancer Center at Jefferson have shown that loss of the retinoblastoma tumor suppressor gene (RB) in triple negative breast cancer patients is associated with ...
Dec 09, 2011 |
not rated yet |
0
New 'Achilles' heel' in breast cancer: tumor cell mitochondria
Researchers at the Kimmel Cancer Center at Jefferson have identified cancer cell mitochondria as the unsuspecting powerhouse and "Achilles' heel" of tumor growth, opening up the door for new therapeutic targets in breast ...
Dec 01, 2011 |
not rated yet |
0
|
